590782388	590782388	CD	B-NP	O
|	|	NN	I-NP	O
NCMC	NCMC	NN	I-NP	O
|	|	NN	I-NP	O
87702030	87702030	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
5120944	5120944	CD	B-NP	O
|	|	CC	I-NP	O
10/22/2004	10/22/2004	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	O
Community-Acquired	Community-Acquired	NNP	I-NP	O
Pneumonia	Pneumonia	NNP	I-NP	O
|	|	NNP	I-NP	O
|	|	NNP	I-NP	O
DIS	DIS	NNP	I-NP	O
|	|	NNP	I-NP	O
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
6/3/2004	6/3/2004	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Discharge	Discharge	NNP	B-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
9/22/2004	9/22/2004	CD	B-NP	O
******	******	SYM	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
ORDERS	ORDERS	NNS	I-NP	O
******	******	SYM	O	O
WARFORD	WARFORD	NNP	B-NP	O
,	,	,	O	O
CHONG	CHONG	NNP	B-NP	O
185-13-97-9	185-13-97-9	CD	I-NP	O
Ville	Ville	NNP	I-NP	O
Service	Service	NNP	I-NP	O
:	:	:	O	O
MED	MED	NNP	B-NP	O
DISCHARGE	DISCHARGE	NNP	I-NP	O
PATIENT	PATIENT	NNP	I-NP	O
ON	ON	NNP	I-NP	O
:	:	:	O	O
10/22/04	10/22/04	CD	B-NP	O
AT	AT	NN	I-NP	O
01	01	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
PM	PM	NNP	I-NP	O
CONTINGENT	CONTINGENT	NNP	I-NP	O
UPON	UPON	NNP	I-NP	O
Not	Not	NNP	I-NP	O
Applicable	Applicable	NNP	I-NP	O
WILL	WILL	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
ORDER	ORDER	NNP	I-NP	O
BE	BE	NNP	I-NP	O
USED	USED	NNP	I-NP	O
AS	AS	NNP	I-NP	O
THE	THE	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
SUMMARY	SUMMARY	NNP	I-NP	O
:	:	:	O	O
YES	YES	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
LIBERT	LIBERT	NNP	B-NP	O
,	,	,	O	O
RUFUS	RUFUS	NNP	B-NP	O
S.	S.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
CODE	CODE	NNP	I-NP	O
STATUS	STATUS	NNP	I-NP	O
:	:	:	O	O
Full	Full	JJ	B-NP	O
code	code	NN	I-NP	O
DISPOSITION	DISPOSITION	NN	I-NP	O
:	:	:	O	O
Home	Home	NN	B-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
ALBUTEROL	ALBUTEROL	NN	B-NP	O
INHALER	INHALER	NN	I-NP	O
2	2	CD	I-NP	O
PUFF	PUFF	NN	I-NP	O
INH	INH	NN	I-NP	O
QID	QID	NNP	I-NP	O
PRN	PRN	NNP	I-NP	O
Shortness	Shortness	NNP	I-NP	O
of	of	IN	B-PP	O
Breath	Breath	NNP	B-NP	O
DEXEDRINE	DEXEDRINE	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
DEXTROAMPHETAMINE	DEXTROAMPHETAMINE	NNP	I-NP	O
SULFATE	SULFATE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
10	10	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
ROBITUSSIN	ROBITUSSIN	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
GUAIFENESIN	GUAIFENESIN	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
10	10	CD	I-NP	O
MILLILITERS	MILLILITERS	NNS	I-NP	O
PO	PO	NN	I-NP	O
Q4H	Q4H	NN	I-NP	O
PRN	PRN	NN	I-NP	O
Other	Other	JJ	B-ADJP	O
:	:	:	O	O
cough	cough	NN	B-NP	O
LEVOTHYROXINE	LEVOTHYROXINE	NNP	I-NP	O
SODIUM	SODIUM	NNP	I-NP	O
125	125	CD	I-NP	O
MCG	MCG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
LISINOPRIL	LISINOPRIL	NNP	I-NP	O
30	30	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
Starting	Starting	NNP	I-NP	O
on	on	IN	B-PP	O
4/4	4/4	CD	B-NP	O
Alert	Alert	NNP	I-NP	O
overridden	overridden	JJ	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
9/12/04	9/12/04	CD	B-NP	O
by	by	IN	B-PP	O
DELVEECHIO	DELVEECHIO	NNP	B-NP	O
,	,	,	O	O
KENT	KENT	NNP	B-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
POTASSIUM	POTASSIUM	NNP	B-NP	O
CHLORIDE	CHLORIDE	NNP	I-NP	O
&	&	CC	I-NP	O
LISINOPRIL	LISINOPRIL	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
monitoring	monitor	VBG	B-VP	O
METOPROLOL	METOPROLOL	NN	B-NP	B-DNA
TARTRATE	TARTRATE	NN	I-NP	I-DNA
12.5	12.5	CD	I-NP	I-DNA
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
Starting	Starting	NNP	I-NP	O
Today	Today	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
4/4	4/4	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Take	Take	NNP	I-NP	O
consistently	consistently	RB	B-ADVP	O
with	with	IN	B-PP	O
meals	meal	NNS	B-NP	O
or	or	CC	B-PP	O
on	on	IN	B-PP	O
empty	empty	JJ	B-NP	O
stomach	stomach	NN	I-NP	O
.	.	.	O	O

VITAMIN	VITAMIN	NN	B-NP	O
E	E	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
TOCOPHEROL-DL-ALPHA	TOCOPHEROL-DL-ALPHA	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
400	400	CD	I-NP	O
UNITS	UNITS	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
REMERON	REMERON	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
MIRTAZAPINE	MIRTAZAPINE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
7.5	7.5	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QHS	QHS	NNP	I-NP	O
Number	Number	NNP	I-NP	O
of	of	IN	B-PP	O
Doses	Doses	NNP	B-NP	O
Required	Required	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
approximate	approximate	JJ	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
:	:	:	O	O
2	2	CD	B-NP	O
LAMICTAL	LAMICTAL	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
LAMOTRIGINE	LAMOTRIGINE	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
200	200	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
BID	BID	NNP	I-NP	O
Number	Number	NNP	I-NP	O
of	of	IN	B-PP	O
Doses	Doses	NNP	B-NP	O
Required	Required	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
approximate	approximate	JJ	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
:	:	:	O	O
8	8	CD	B-NP	O
PLAVIX	PLAVIX	CD	I-NP	O
-LRB-	-LRB-	HYPH	B-NP	O
CLOPIDOGREL	CLOPIDOGREL	NN	I-NP	B-protein
-RRB-	-RRB-	HYPH	B-NP	O
75	75	CD	I-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
QD	QD	NN	I-NP	O
*	*	SYM	B-VP	O
LIPITOR	LIPITOR	NN	B-NP	O
10	10	CD	I-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
QD	QD	NN	I-NP	O
PREMPRO	PREMPRO	NN	I-NP	O
0.45	0.45	CD	I-NP	O
mg/mg	mg/mg	NN	I-NP	O
PO	PO	NN	I-NP	O
QD	QD	NN	I-NP	O
Instructions	Instruction	NNS	I-NP	O
:	:	:	O	O
0.45	0.45	CD	B-NP	O
/	/	SYM	I-NP	B-protein
1.5	1.5	CD	I-NP	I-protein
mg	mg	NN	I-NP	I-protein
formulation	formulation	NN	I-NP	I-protein
LEVOFLOXACIN	LEVOFLOXACIN	NN	I-NP	I-protein
500	500	CD	I-NP	I-protein
MG	MG	NN	I-NP	I-protein
PO	PO	NN	I-NP	I-protein
QD	QD	NN	I-NP	I-protein
X	X	SYM	B-VP	I-protein
9	9	CD	B-NP	I-protein
doses	dose	NNS	I-NP	I-protein
Food/Drug	Food/Drug	NNP	B-NP	I-protein
Interaction	Interaction	NNP	I-NP	I-protein
Instruction	Instruction	NNP	I-NP	I-protein
Administer	Administer	NNP	I-NP	I-protein
iron	iron	NN	I-NP	I-protein
products	product	NNS	I-NP	I-protein
a	a	DT	B-NP	O
minimum	minimum	NN	I-NP	O
of	of	IN	B-PP	O
2	2	CD	B-NP	O
hours	hour	NNS	I-NP	O
before	before	IN	B-PP	O
or	or	CC	I-PP	O
after	after	IN	I-PP	O
a	a	DT	B-NP	O
levofloxacin	levofloxacin	NN	I-NP	O
or	or	CC	I-NP	O
ciprofloxacin	ciprofloxacin	NN	I-NP	O
dose	dose	NN	I-NP	O
dose	dose	NN	I-NP	O
If	If	IN	B-SBAR	O
on	on	IN	B-PP	O
tube	tube	NN	B-NP	O
feeds	feed	NNS	I-NP	O
,	,	,	O	O
please	please	VB	B-VP	O
cycle	cycle	NN	B-NP	B-protein
-LRB-	-LRB-	NN	I-NP	I-protein
hold	hold	VBP	B-VP	O
1	1	CD	B-NP	O
hr	hr	NN	I-NP	O
before	before	IN	B-PP	O
to	to	TO	B-PP	O
2	2	CD	B-NP	O
hr	hr	NN	I-NP	O
after	after	IN	B-PP	O
-RRB-	-RRB-	NN	B-NP	B-protein
Take	Take	NN	I-NP	I-protein
2	2	CD	B-NP	I-protein
hours	hour	NNS	I-NP	I-protein
before	before	IN	B-PP	O
or	or	CC	B-NP	O
2	2	CD	I-NP	O
hours	hour	NNS	I-NP	O
after	after	IN	B-PP	O
dairy	dairy	NN	B-NP	O
products	product	NNS	I-NP	O
.	.	.	O	O

DIET	DIET	NN	B-NP	O
:	:	:	O	O
4	4	CD	B-NP	O
gram	gram	NN	I-NP	O
Sodium	Sodium	NN	I-NP	O
RETURN	RETURN	NN	I-NP	O
TO	TO	NN	I-NP	O
WORK	WORK	NN	I-NP	O
:	:	:	O	O
IN	IN	NN	B-NP	B-protein
7	7	CD	I-NP	I-protein
DAYS	DAYS	NNP	I-NP	O
FOLLOW	FOLLOW	NNP	I-NP	O
UP	UP	NNP	I-NP	O
APPOINTMENT	APPOINTMENT	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
S	S	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
:	:	:	O	O
Dr.	Dr.	NNP	B-NP	O
Behran	Behran	NNP	I-NP	O
9/10/04	9/10/04	CD	I-NP	O
scheduled	schedule	VBN	B-VP	O
,	,	,	O	O
ALLERGY	ALLERGY	NNP	B-NP	O
:	:	:	O	O
Demerol	Demerol	NNP	B-NP	O
,	,	,	O	O
Penicillins	Penicillins	NNP	B-NP	O
,	,	,	O	O
Codeine	Codeine	NNP	B-NP	O
,	,	,	O	O
Morphine	Morphine	NNP	B-NP	O
,	,	,	O	O
Sulfa	Sulfa	NNP	B-NP	O
,	,	,	O	O
IV	IV	CD	B-NP	O
Contrast	Contrast	NN	I-NP	O
ADMIT	ADMIT	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
:	:	:	O	O
Community-Acquired	Community-Acquired	JJ	B-NP	O
Pneumonia	Pneumonia	NN	I-NP	O
PRINCIPAL	PRINCIPAL	JJ	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
;	;	:	O	O
Responsible	Responsible	JJ	B-ADJP	O
After	After	IN	B-PP	O
Study	Study	NNP	B-NP	O
for	for	IN	B-PP	O
Causing	Causing	NNP	B-NP	O
Admission	Admission	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Community-Acquired	Community-Acquired	NNP	I-NP	O
Pneumonia	Pneumonia	NNP	I-NP	O
OTHER	OTHER	NNP	I-NP	O
DIAGNOSIS	DIAGNOSIS	NNP	I-NP	O
;	;	:	O	O
Conditions	Condition	NNS	B-NP	O
,	,	,	O	O
Infections	Infection	NNS	B-NP	O
,	,	,	O	O
Complications	Complication	NNS	B-NP	O
,	,	,	O	O
affecting	affect	VBG	B-VP	O
Treatment/Stay	Treatment/Stay	NNP	B-NP	O
sz	sz	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
seizure	seizure	NN	I-NP	O
disorder	disorder	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
graves	grave	VBZ	B-VP	O
-LRB-	-LRB-	NNP	B-NP	O
Graves	Graves	NNP	I-NP	O
'	'	POS	B-NP	O
disease	disease	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
hypothyroidism	hypothyroidism	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
hypothyroidism	hypothyroidism	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
HTN	HTN	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
hypertension	hypertension	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
hyperchol	hyperchol	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
hyperlipidemia	hyperlipidemia	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
ADD	ADD	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
attention	attention	NN	I-NP	O
deficit	deficit	NN	I-NP	O
disorder	disorder	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
RLL	RLL	NN	I-NP	O
PNA	PNA	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
community	community	NN	I-NP	O
acquired	acquire	VBD	B-VP	O
pneumonia	pneumonia	NN	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
tachycardia	tachycardia	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
tachycardia	tachycardia	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
OPERATIONS	OPERATIONS	NNS	I-NP	O
AND	AND	CC	I-NP	O
PROCEDURES	PROCEDURES	NNS	I-NP	O
:	:	:	O	O
NONE	NONE	NN	B-NP	O
OTHER	OTHER	NN	I-NP	O
TREATMENTS/PROCEDURES	TREATMENTS/PROCEDURES	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
NOT	NOT	NNP	I-NP	O
IN	IN	NNP	I-NP	O
O.R.	O.R.	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
NONE	NONE	NNP	I-NP	O
BRIEF	BRIEF	NNP	I-NP	O
RESUME	RESUME	NNP	I-NP	O
OF	OF	IN	B-PP	O
HOSPITAL	HOSPITAL	NNP	B-NP	O
COURSE	COURSE	NNP	I-NP	O
:	:	:	O	O
62	62	CD	B-NP	O
F	F	NN	I-NP	O
admitted	admit	VBD	B-VP	O
w	w	NN	B-NP	O
/	/	SYM	B-ADJP	O
R-sided	R-sided	JJ	B-NP	O
suspected	suspect	VBN	I-NP	O
pneumococcal	pneumococcal	JJ	I-NP	O
pneumonia	pneumonia	NN	I-NP	O
.	.	.	O	O

PMH	PMH	NN	B-NP	O
notable	notable	JJ	B-ADJP	O
for	for	IN	B-PP	O
1	1	CD	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
Seizure	Seizure	NN	I-NP	O
D/O	D/O	NN	I-NP	O
:	:	:	O	O
temporal	temporal	JJ	B-NP	O
partial	partial	JJ	I-NP	O
sz	sz	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
manifests	manifest	VBZ	B-VP	O
as	as	IN	B-PP	O
confusion	confusion	NN	B-NP	O
,	,	,	O	O
not	not	RB	O	O
Tonic-Clonic	Tonic-Clonic	JJ	B-NP	B-protein
-RRB-	-RRB-	NN	I-NP	I-protein
,	,	,	O	O
last	last	JJ	B-NP	B-protein
Sz	Sz	NN	I-NP	I-protein
1	1	CD	I-NP	I-protein
month	month	NN	I-NP	I-protein
PTA	PTA	NN	I-NP	I-protein
,	,	,	O	O
recently	recently	RB	B-ADVP	O
increased	increase	VBD	B-VP	O
Lamictal	Lamictal	JJ	B-NP	O
200mg	200mg	NN	I-NP	O
BID	BID	NN	I-NP	O
;	;	:	O	O
2	2	CD	B-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Subclavian	Subclavian	NNP	I-NP	O
Steal	Steal	NNP	I-NP	O
Syndrome	Syndrome	NNP	I-NP	O
stented	stente	VBD	B-VP	O
@	@	NNP	B-NP	O
I.pemident	I.pemident	NNP	I-NP	O
Medical	Medical	NNP	I-NP	O
Center	Center	NNP	I-NP	O
And	And	CC	O	O
Clinics	Clinics	NNP	B-NP	O
3	3	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Vertebral	Vertebral	NNP	I-NP	O
Art	Art	NNP	I-NP	O
Stenosis	Stenosis	NNP	I-NP	O
;	;	:	O	O
4	4	CD	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
Posterior	Posterior	JJ	I-NP	O
Ciruclation	Ciruclation	NN	I-NP	O
TIA	TIA	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
admitted	admit	VBN	B-VP	O
to	to	TO	B-PP	O
Burlo	Burlo	NNP	B-NP	O
Dera	Dera	NNP	I-NP	O
Hospital	Hospital	NNP	I-NP	O
1998	1998	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
,	,	,	O	O
on	on	IN	B-PP	O
clopidogrel	clopidogrel	NN	B-NP	O
now	now	RB	B-ADVP	O
;	;	:	O	O
5	5	CD	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
Graves	Graves	NN	I-NP	O
'	'	POS	B-NP	O
Disease	Disease	NN	I-NP	O
,	,	,	O	O
now	now	RB	B-ADJP	O
hypothyroid	hypothyroid	JJ	I-ADJP	O
on	on	IN	B-PP	O
replacement	replacement	NN	B-NP	O
;	;	:	O	O
6	6	CD	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
HTN	HTN	NN	I-NP	O
w	w	NN	I-NP	O
/	/	SYM	B-VP	O
last	last	JJ	B-NP	O
stress-ETT	stress-ETT	NN	I-NP	O
4/23	4/23	CD	B-NP	O
@	@	NNP	I-NP	O
Manstates	Manstates	NNP	I-NP	O
Sidme	Sidme	NNP	I-NP	O
Community	Community	NNP	I-NP	O
Hospital	Hospital	NNP	I-NP	O
wnl	wnl	NN	I-NP	O
;	;	:	O	O
7	7	CD	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
hypercholestrolemia	hypercholestrolemia	NN	I-NP	O
;	;	:	O	O
8	8	CD	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
ADD	ADD	NN	I-NP	O
;	;	:	O	O
9	9	CD	B-NP	O
-RRB-	-RRB-	HYPH	I-NP	O
100	100	CD	I-NP	O
pk-yr	pk-yr	JJ	I-NP	O
current	current	JJ	I-NP	O
tob	tob	NN	I-NP	O
.	.	.	O	O

CURRENTLY	CURRENTLY	NN	B-NP	O
:	:	:	O	O
in	in	IN	B-PP	O
USOH	USOH	NN	B-NP	O
until	until	IN	B-SBAR	O
2wks	2wk	NNS	B-NP	O
PTA	PTA	NN	I-NP	B-protein
developped	developpe	VBD	B-VP	O
productive	productive	JJ	B-NP	O
cough	cough	NN	I-NP	O
with	with	IN	B-PP	O
yellow	yellow	JJ	B-NP	O
sputum	sputum	NN	I-NP	O
,	,	,	O	O
rhinnorreah	rhinnorreah	NN	B-NP	O
,	,	,	O	O
facial	facial	JJ	B-NP	O
pain	pain	NN	I-NP	O
-	-	HYPH	O	O
>	>	SYM	O	O
sxs	sx	NNS	B-NP	O
resolved	resolve	VBN	B-VP	O
spontaneously	spontaneously	RB	B-ADVP	O
over	over	IN	B-NP	O
1	1	CD	I-NP	O
wk	wk	NN	I-NP	O
-	-	HYPH	O	O
>	>	SYM	O	O
howver	howver	NN	B-NP	O
,	,	,	O	O
night	night	NN	B-NP	B-protein
PTA	PTA	NN	I-NP	I-protein
,	,	,	O	O
developped	developpe	VBD	B-VP	O
+	+	SYM	B-NP	O
+	+	SYM	B-NP	O
chills	chill	NNS	I-NP	O
,	,	,	O	O
w	w	NN	B-NP	O
/	/	SYM	B-VP	O
right-sided	right-sided	JJ	B-NP	O
mid-scapular	mid-scapular	JJ	I-NP	O
back	back	JJ	I-NP	O
pain	pain	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
non-radiating	non-radiating	JJ	B-ADJP	O
,	,	,	O	O
non-pleuritic	non-pleuritic	JJ	B-ADJP	O
,	,	,	O	O
exacerbated	exacerbate	VBN	B-VP	O
by	by	IN	B-PP	O
coughing	cough	VBG	B-VP	O
-RRB-	-RRB-	NN	B-NP	B-protein
,	,	,	O	O
poor	poor	JJ	B-NP	O
balance/difficulty	balance/difficulty	NN	I-NP	O
standing	standing	NN	I-NP	O
,	,	,	O	O
malaise	malaise	NN	B-NP	O
&	&	CC	I-NP	O
cough	cough	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
ED	ED	NN	B-NP	O
:	:	:	O	O
diagnostics	diagnostic	NNS	B-NP	O
notable	notable	JJ	B-ADJP	O
for	for	IN	B-PP	O
WBC	WBC	NNP	B-NP	O
23.8	23.8	CD	I-NP	O
.	.	.	O	O

CXR	CXR	NN	B-NP	B-protein
revealed	reveal	VBD	B-VP	O
a	a	DT	B-NP	O
consolidation	consolidation	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
superior	superior	JJ	I-NP	O
segment	segment	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
RLL	RLL	NN	I-NP	B-protein
.	.	.	O	O

HOSPITAL	HOSPITAL	JJ	B-NP	O
COURSE	COURSE	NN	I-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
PULM	PULM	NN	I-NP	O
:	:	:	O	O
Suspected	Suspect	VBN	B-NP	O
R-sided	R-sided	JJ	I-NP	O
CAP	CAP	NN	I-NP	O
w	w	NN	I-NP	O
/	/	SYM	B-VP	O
initial	initial	JJ	B-NP	O
concerns	concern	NNS	I-NP	O
including	include	VBG	B-PP	O
ill-feeling/appearing	ill-feeling/appearing	JJ	B-NP	O
,	,	,	O	O
ST	ST	NN	B-NP	O
=	=	SYM	B-VP	O
100-120s	100-120s	CD	B-NP	O
,	,	,	O	O
BP	BP	NN	B-NP	O
=	=	SYM	B-VP	O
90s/60s	90s/60s	CD	B-NP	O
,	,	,	O	O
2-4L	2-4L	NN	B-NP	O
O2	O2	NN	I-NP	O
requirement	requirement	NN	I-NP	O
,	,	,	O	O
&	&	CC	B-NP	O
lekocytosis	lekocytosis	NN	I-NP	O
,	,	,	O	O
mild	mild	JJ	B-NP	O
ARF	ARF	NNP	I-NP	O
&	&	CC	I-NP	O
underlying	underlie	VBG	I-NP	O
tobacco	tobacco	NN	I-NP	O
.	.	.	O	O

-	-	HYPH	B-NP	O
received	receive	VBN	I-NP	O
cefotax	cefotax	NN	I-NP	O
+	+	SYM	O	O
azithro/flagyl	azithro/flagyl	NN	B-NP	O
empirically	empirically	RB	B-ADVP	O
-LRB-	-LRB-	IN	B-PP	O
no	no	DT	B-NP	O
FQ	FQ	NN	I-NP	B-protein
IV	IV	CD	I-NP	I-protein
given	give	VBN	I-NP	O
concern	concern	NN	I-NP	O
of	of	IN	B-PP	O
sz	sz	NN	B-NP	O
d/o	d/o	NN	I-NP	O
&	&	CC	O	O
felt	feel	VBD	B-VP	O
OK	OK	NN	B-NP	O
to	to	TO	B-VP	O
challenge	challenge	VB	I-VP	O
w	w	NN	B-NP	O
/	/	SYM	B-NP	O
cephalosporin	cephalosporin	NN	I-NP	O
given	give	VBN	B-VP	O
unclear	unclear	JJ	B-NP	O
remote	remote	JJ	I-NP	O
h/o	h/o	NN	I-NP	O
PCN	PCN	NN	I-NP	O
allergy	allergy	NN	I-NP	O
.	.	.	O	O

-	-	HYPH	B-NP	O
sputum	sputum	NN	I-NP	O
cx	cx	NN	I-NP	O
subsequently	subsequently	RB	B-NP	O
w	w	NN	I-NP	O
/	/	SYM	B-VP	O
widely	widely	RB	B-NP	O
sensitive	sensitive	JJ	I-NP	O
strep	strep	NN	I-NP	O
pneumo	pneumo	NN	I-NP	O
thought	think	VBD	B-VP	O
pathogenic	pathogenic	JJ	B-ADJP	O
.	.	.	O	O

Pt	Pt	NN	B-NP	O
.	.	.	O	O

switched	switch	VBN	B-VP	O
to	to	TO	B-PP	O
IV	IV	CD	B-NP	O
cefotax	cefotax	NN	I-NP	O
alone	alone	RB	B-NP	O
c/w	c/w	JJ	I-NP	O
sensitivititis	sensitivititis	NN	I-NP	O
for	for	IN	B-PP	O
5d	5d	NN	B-NP	O
in	in	IN	B-PP	O
house	house	NN	B-NP	O
-LRB-	-LRB-	NN	I-NP	O
of	of	IN	B-PP	O
note	note	NN	B-NP	O
,	,	,	O	O
PPD	PPD	NN	B-NP	O
negative	negative	JJ	B-NP	O
here	here	RB	I-NP	O
-RRB-	-RRB-	JJ	I-NP	O
-	-	HYPH	I-NP	O
pt	pt	NN	I-NP	O
to	to	TO	B-VP	O
switch	switch	VB	I-VP	O
to	to	TO	B-PP	O
PO	PO	FW	B-NP	O
levo	levo	FW	I-NP	O
as	as	IN	B-PP	O
outpt	outpt	NN	B-NP	O
-LRB-	-LRB-	HYPH	B-VP	O
discussed	discuss	VBN	B-NP	O
w	w	NN	I-NP	O
/	/	SYM	B-NP	O
neurologist	neurologist	NN	I-NP	O
who	who	WP	B-NP	O
like	like	IN	B-PP	O
primary	primary	JJ	B-NP	O
team	team	NN	I-NP	O
believed	believe	VBD	B-VP	O
that	that	IN	B-SBAR	O
PO	PO	NN	B-NP	O
levo	levo	NN	I-NP	O
w	w	NN	I-NP	O
/	/	SYM	O	O
lower	low	JJR	B-NP	O
&	&	CC	I-NP	O
acceptable	acceptable	JJ	I-NP	O
risk	risk	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
;	;	:	O	O
no	no	DT	B-NP	O
amox	amox	NN	I-NP	O
icillin	icillin	NN	I-NP	O
given	give	VBN	B-VP	O
possible	possible	JJ	B-NP	O
PCN	PCN	NN	I-NP	O
allergy	allergy	NN	I-NP	O
&	&	CC	I-NP	O
allergy	allergy	NN	I-NP	O
team	team	NN	I-NP	O
unable	unable	JJ	B-ADJP	O
to	to	TO	B-PP	O
skin-test	skin-test	NN	B-NP	O
for	for	IN	B-PP	O
PCN	PCN	NN	B-NP	B-protein
as	as	IN	B-PP	O
inpt	inpt	NN	B-NP	O
.	.	.	O	O

-	-	HYPH	B-NP	O
after	after	IN	B-PP	O
receiving	receive	VBG	B-VP	O
additional	additional	JJ	B-NP	O
IVFs	IVF	NNS	I-NP	B-protein
on	on	IN	B-PP	O
HODs	HOD	NNS	B-NP	O
#	#	#	B-NP	O
1-2	1-2	CD	I-NP	O
&	&	CC	I-NP	O
bronchodlators	bronchodlator	NNS	I-NP	O
for	for	IN	B-PP	O
suspected	suspect	VBN	B-NP	O
secondary	secondary	JJ	I-NP	O
bronchspasm	bronchspasm	NN	I-NP	O
,	,	,	O	O
pt	pt	NN	B-NP	O
with	with	IN	B-PP	O
definite	definite	JJ	B-NP	O
improvement	improvement	NN	I-NP	O
including	include	VBG	B-PP	O
a	a	DT	B-NP	O
-RRB-	-RRB-	JJ	I-NP	O
symptomatic	symptomatic	JJ	I-NP	O
improvement	improvement	NN	I-NP	O
including	include	VBG	B-PP	O
less	less	JJR	B-NP	O
cough/CP	cough/CP	NN	I-NP	O
;	;	:	O	O
b	b	NN	B-NP	O
-RRB-	-RRB-	HYPH	B-NP	O
stable	stable	JJ	I-NP	O
BPs	BP	NNS	I-NP	O
w/o	w/o	VBP	B-VP	O
IVFs	IVF	NNS	B-NP	B-protein
and	and	CC	O	O
re-institution	re-institution	NN	B-NP	O
of	of	IN	B-PP	O
antihypertensives	antihypertensive	NNS	B-NP	O
;	;	:	O	O
c	c	NN	B-NP	O
-RRB-	-RRB-	:	O	O
no	no	DT	B-NP	O
hypoxia	hypoxia	NN	I-NP	O
including	include	VBG	B-PP	O
w	w	NN	B-NP	O
/	/	SYM	B-NP	O
ambulation	ambulation	NN	I-NP	O
;	;	:	O	O
d	d	NN	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
decreased	decrease	VBD	B-VP	O
HR	HR	NN	B-NP	B-protein
w	w	NN	I-NP	I-protein
/	/	SYM	B-NP	O
max	max	NN	I-NP	O
=	=	SYM	B-VP	O
105	105	CD	B-NP	O
w	w	NN	I-NP	O
/	/	SYM	B-NP	O
ambulation	ambulation	NN	I-NP	O
;	;	:	O	O
e	e	NN	B-NP	O
-RRB-	-RRB-	:	O	O
no	no	DT	B-NP	O
fevers	fever	NNS	I-NP	O
&	&	CC	O	O
dec	dec	VB	B-VP	O
WBC	WBC	NNP	B-NP	B-cell_type
;	;	:	O	O
e	e	NN	B-NP	O
-RRB-	-RRB-	HYPH	O	O
resolved	resolve	VBN	B-NP	O
ARF	ARF	NN	I-NP	B-protein
.	.	.	O	O

-	-	:	O	O
of	of	IN	B-PP	O
note	note	NN	B-NP	O
,	,	,	O	O
received	receive	VBD	B-VP	O
flu	flu	NN	B-NP	O
&	&	CC	I-NP	O
pneumococcal	pneumococcal	JJ	I-NP	O
vaccines	vaccine	NNS	I-NP	O
prior	prior	RB	B-ADVP	O
to	to	TO	B-PP	O
DC	DC	NN	B-NP	B-cell_type
;	;	:	O	O
was	be	VBD	B-VP	O
on	on	IN	B-PP	O
LMWH	LMWH	NN	B-NP	B-protein
prophylaxis	prophylaxis	NN	I-NP	I-protein
throughout	throughout	IN	B-PP	I-protein
hospitalization	hospitalization	NN	B-NP	I-protein
2	2	CD	I-NP	I-protein
-RRB-	-RRB-	NNP	I-NP	O
NEW	NEW	NNP	I-NP	O
LBBB	LBBB	NNP	I-NP	O
:	:	:	O	O
2	2	CD	B-NP	O
separate	separate	JJ	I-NP	O
episodes	episode	NNS	I-NP	O
of	of	IN	B-PP	O
transient	transient	JJ	B-NP	O
LBBB	LBBB	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
on	on	IN	B-PP	O
5/29	5/29	CD	B-NP	O
,	,	,	O	O
and	and	CC	O	O
6/15	6/15	CD	B-NP	O
-RRB-	-RRB-	SYM	I-NP	O
w	w	NN	I-NP	O
/	/	SYM	B-NP	O
likely	likely	JJ	I-NP	O
sinus	sinus	NN	I-NP	O
rhythm	rhythm	NN	I-NP	O
and	and	CC	I-NP	O
tachy	tachy	NN	I-NP	O
to	to	TO	B-PP	O
110s	110s	CD	B-NP	O
on	on	IN	B-PP	O
12	12	CD	B-NP	O
lead	lead	NN	I-NP	O
ECG	ECG	NN	I-NP	O
.	.	.	O	O

Asymptomatic	Asymptomatic	JJ	B-NP	O
w	w	NN	I-NP	O
/	/	SYM	B-NP	O
negative	negative	JJ	I-NP	B-protein
serial	serial	JJ	I-NP	I-protein
cardiac	cardiac	JJ	I-NP	I-protein
enzymes	enzyme	NNS	I-NP	I-protein
-	-	HYPH	O	O
>	>	SYM	B-NP	O
thought	think	VBD	B-VP	O
likely	likely	RB	B-NP	O
2/2	2/2	CD	I-NP	O
rate-related	rate-related	JJ	I-NP	O
LBBB	LBBB	NN	I-NP	O
conduction	conduction	NN	I-NP	O
dz	dz	NN	I-NP	O
as	as	IN	B-SBAR	O
not	not	RB	O	O
appear	appear	VB	B-VP	O
w	w	NN	B-NP	O
/	/	SYM	B-NP	O
HR	HR	NN	I-NP	O
<	<	SYM	B-NP	O
105	105	CD	I-NP	O
.	.	.	O	O

Of	Of	IN	B-PP	O
note	note	NN	B-NP	O
,	,	,	O	O
tachycardia	tachycardia	NN	B-NP	O
thought	think	VBD	B-VP	O
2/2	2/2	CD	B-NP	O
infection	infection	NN	I-NP	O
+	+	SYM	B-NP	O
/	/	SYM	B-VP	O
-	-	HYPH	B-NP	O
initial	initial	JJ	I-NP	O
B-blocker	B-blocker	NN	I-NP	O
withdrawal	withdrawal	NN	I-NP	O
ADDITIONAL	ADDITIONAL	NN	I-NP	O
COMMENTS	COMMENTS	NNS	I-NP	O
:	:	:	O	O
Please	Please	NN	B-NP	O
note	note	NN	I-NP	O
that	that	IN	B-NP	O
we	we	PRP	B-NP	O
have	have	VBP	B-VP	O
made	make	VBN	I-VP	O
no	no	DT	B-NP	O
changes	change	NNS	I-NP	O
to	to	TO	B-PP	O
your	your	PRP$	B-NP	O
medications	medication	NNS	I-NP	O
which	which	WDT	B-NP	O
you	you	PRP	B-NP	O
were	be	VBD	B-VP	O
taking	take	VBG	I-VP	O
prior	prior	JJ	B-ADVP	O
to	to	TO	B-PP	O
your	your	PRP$	B-NP	O
hospitalization	hospitalization	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
you	you	PRP	B-NP	O
should	should	MD	B-VP	O
continue	continue	VB	I-VP	O
them	them	PRP	B-NP	O
as	as	IN	B-PP	O
per	per	IN	B-PP	O
your	your	PRP$	B-NP	O
primary	primary	JJ	I-NP	O
care	care	NN	I-NP	O
physician	physician	NN	I-NP	O
's	's	POS	B-NP	O
instructions	instruction	NNS	I-NP	O
.	.	.	O	O

You	You	PRP	B-NP	B-protein
are	be	VBP	B-VP	O
being	be	VBG	I-VP	O
discharged	discharge	VBN	I-VP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
9	9	CD	I-NP	O
day	day	NN	I-NP	O
course	course	NN	I-NP	O
of	of	IN	B-PP	O
Levofloxacin	Levofloxacin	NN	B-NP	B-protein
-LRB-	-LRB-	HYPH	B-NP	I-protein
500mg	500mg	CD	I-NP	I-protein
PO	PO	NN	I-NP	I-protein
QD	QD	NN	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
to	to	TO	B-VP	O
treat	treat	VB	I-VP	O
your	your	PRP$	B-NP	O
pneumonia	pneumonia	NN	I-NP	O
.	.	.	O	O

There	There	EX	B-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
slight	slight	JJ	I-NP	O
risk	risk	NN	I-NP	O
that	that	IN	B-SBAR	O
this	this	DT	B-NP	O
medication	medication	NN	I-NP	O
lowers	lower	VBZ	B-VP	O
the	the	DT	B-NP	O
seizure	seizure	NN	I-NP	O
threshhold	threshhold	NN	I-NP	O
.	.	.	O	O

If	If	IN	B-SBAR	O
you	you	PRP	B-NP	O
develop	develop	VBP	B-VP	O
any	any	DT	B-NP	O
concerns	concern	NNS	I-NP	O
,	,	,	O	O
please	please	VB	B-VP	O
seek	seek	JJ	B-NP	O
medical	medical	JJ	I-NP	O
attention	attention	NN	I-NP	O
immediately	immediately	RB	B-ADVP	O
.	.	.	O	O

Please	Please	NN	B-NP	O
follow-up	follow-up	NN	I-NP	O
with	with	IN	B-PP	O
your	your	PRP$	B-NP	O
primary	primary	JJ	I-NP	O
care	care	NN	I-NP	O
physician	physician	NN	I-NP	O
as	as	IN	B-SBAR	O
outlined	outline	VBN	B-VP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
CONDITION	CONDITION	NN	I-NP	O
:	:	:	O	O
Stable	Stable	JJ	B-NP	O
TO	TO	NN	I-NP	O
DO/PLAN	DO/PLAN	NN	I-NP	O
:	:	:	O	O
No	No	DT	B-NP	O
dictated	dictated	JJ	I-NP	O
summary	summary	NN	I-NP	O
ENTERED	ENTERED	NNP	I-NP	O
BY	BY	NNP	I-NP	O
:	:	:	O	O
PELLA	PELLA	NNP	B-NP	O
,	,	,	O	O
GRAIG	GRAIG	NNP	B-NP	B-protein
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
DN10	DN10	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
10/22/04	10/22/04	CD	I-NP	O
@	@	HYPH	B-NP	O
12	12	CD	I-NP	O
******	******	SYM	I-NP	O
END	END	NN	I-NP	O
OF	OF	IN	B-PP	O
DISCHARGE	DISCHARGE	NN	B-NP	O
ORDERS	ORDERS	NNS	I-NP	O
******	******	SYM	B-NP	O

